0 followers
Akston Biosciences Corporation leverages its novel fusion protein platform to develop and manufacture new classes of biologics, including vaccines, ultra-long-acting insulins, and autoimmune disease therapies.
Todd Zion
Immunome
2 followers
Elicio Therapeutics
1 follower
Nunzio Marc DeSantis Architects
1 follower
Artiva Biotherapeutics
1 follower
Lucid Management and Capital Partners LP
1 follower
Amgen
208 followers
Capricor Therapeutics
1 follower
Merkle
63 followers
Medidata Solutions
25 followers
FS
15 followers
Cytokinetics
11 followers
Explore companies